CEFEPIME

被引：52

作者：

CUNHA, BA ^{[1
]}

GILL, MV ^{[1
]}

机构：

[1] SUNY STONY BROOK, SCH MED, STONY BROOK, NY 11794 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1995年 / 79卷 / 04期

关键词：

D O I：

10.1016/S0025-7125(16)30035-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cefepime is a fourth-generation cephalosporin with gram-positive and gram-negative activity, including anti-Pseudomonas activity. It is useful in treating serious infections associated with Pseudomonas aeruginosa, such as nosocomial pneumonias and infections in febrile leukopenic compromised hosts. Because cefepime has low resistance potential and is active against ceftazidime-resistant organisms, it is being used in place of ceftazidime.

引用

收藏

页码：721 / 732

页数：12

相关论文

共 42 条

[1] CEFEPIME - PHARMACOKINETICS AND CLINICAL-RESPONSE IN PATIENTS WITH CYSTIC-FIBROSIS [J].

ARGUEDAS, AG ;

STUTMAN, HR ;

ZALESKA, M ;

KNUPP, CA ;

MARKS, MI ;

NUSSBAUM, E .

AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1992, 146 (07) :797-802

[2] PHARMACOKINETICS OF CEFEPIME IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].

BARBHAIYA, R ;

KNUPP, CA ;

PFEFFER, M ;

ZACCARDELLI, D ;

DUKES, GM ;

MATTERN, W ;

PITTMAN, KA ;

HAK, LJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1387-1391

[3] EFFECTS OF AGE AND GENDER ON PHARMACOKINETICS OF CEFEPIME [J].

BARBHAIYA, RH ;

KNUPP, CA ;

PITTMAN, KA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1181-1185

[4] PHARMACOKINETICS OF CEFEPIME AFTER SINGLE AND MULTIPLE INTRAVENOUS ADMINISTRATIONS IN HEALTHY-SUBJECTS [J].

BARBHAIYA, RH ;

FORGUE, ST ;

GLEASON, CR ;

KNUPP, CA ;

PITTMAN, KA ;

WEIDLER, DJ ;

MOVAHHED, H ;

TENNEY, J ;

MARTIN, RR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :552-557

[5] SAFETY, TOLERANCE, AND PHARMACOKINETICS OF CEFEPIME ADMINISTERED INTRAMUSCULARLY TO HEALTHY-SUBJECTS [J].

BARBHAIYA, RH ;

KNUPP, CA ;

TENNEY, J ;

MARTIN, RR ;

WEIDLER, DJ ;

PITTMAN, KA .

JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (10) :900-910

[6]

BARBHAIYA RH, 1991, DRUG METAB DISPOS, V19, P68

[7] PHARMACOKINETICS OF CEFEPIME IN SUBJECTS WITH RENAL-INSUFFICIENCY [J].

BARBHAIYA, RH ;

KNUPP, CA ;

FORGUE, ST ;

MATZKE, GR ;

GUAY, DRP ;

PITTMAN, KA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) :268-276

[8]

BARRIERE SL, 1993, AM J MED S4A, V95, P18

[9] COMPARATIVE ACTIVITY OF CEFEPIME, ALONE AND IN COMBINATION, AGAINST CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA AND PSEUDOMONAS-CEPACIA FROM CYSTIC-FIBROSIS PATIENTS [J].

BOSSO, JA ;

SAXON, BA ;

MATSEN, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :783-784

[10] CEFEPIME CONCENTRATIONS IN BRONCHIAL-MUCOSA AND SERUM FOLLOWING A SINGLE 2 GRAM INTRAVENOUS DOSE [J].

CHADHA, D ;

WISE, R ;

BALDWIN, DR ;

ANDREWS, JM ;

ASHBY, JP ;

HONEYBOURNE, D .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (06) :959-963

← 1 2 3 4 5 →